Found 0 matching trials
Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001 EARLY_PHASE1 This is an open- label, non- randomized, uncontrolled, dose-escalation pilo...
Show More Location
Multiple Locations
Learn More & Join Trial
An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra) Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure PHASE3 The purpose of this study is to evaluate efficacy, safety and tolerance of ...
Show More Learn More & Join Trial
Transgender Estradiol Affirming Therapy PHASE2 The purpose of this open label, pilot, randomized clinical trial is to eval...
Show More Location
Washington University Transgender Center
Learn More & Join Trial
An International Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B N/A Alprolix (rFIXFc) is a recombinant extended half-life coagulation factor pr...
Show More Location
Swedish Orphan Biovitrum Research Site
Learn More & Join Trial
Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B PHASE3 The Study's Primary Objective is to evaluate the pharmacokinetics, safety (...
Show More Location
RUSH University Medical Center
Learn More & Join Trial
The Effectiveness of Recombinant Coagulation Factor IX With Recombinant Albumin (rIX-FP) in Severe Hemophilia B Patients PHASE4 The pivotal clinical data support prolonged dosing intervals of up to 14 da...
Show More Location
National Taiwan University Hospital
Learn More & Join Trial
A Gene Therapy Study for Hemophilia B PHASE2 A Phase 1/2, Open-Label, Non-Randomized, Dose-Escalation Study of SPK-9001 ...
Show More Location
UC Davis Comprehensive Cancer Center
Learn More & Join Trial
Efficacy and Safety Study of Urapidil Alone or With Esmolol in Treating Acute Hypertensive Intracerebral Hemorrhage N/A The objective of this study is to investigate the efficacy and safety of ur...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Recombinant Factor IX Product, IB1001, in Previously Treated Subjects With Hemophilia B PHASE3 To evaluate the safety (acute adverse effects associated with infusions, an...
Show More Location
Multiple Locations
Learn More & Join Trial
An Open Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients PHASE3 To compare the first and second recovery assessments on Replenine®-VF and t...
Show More Location
Klinika Hematologii Instytutu Medycyny Wewnetrznej
Learn More & Join Trial